Caldwell Sutter Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.29K | Buy |
100
+27
| +37% | +$2.24K | ﹤0.01% | 560 |
|
|
2025
Q1 | $5.92K | Buy |
73
+20
| +38% | +$1.62K | ﹤0.01% | 605 |
|
|
2024
Q4 | $4.77K | Hold |
53
| – | – | ﹤0.01% | 639 |
|
|
2024
Q3 | $5.24K | Hold |
53
| – | – | ﹤0.01% | 633 |
|
|
2024
Q2 | $4.91K | Hold |
53
| – | – | ﹤0.01% | 635 |
|
|
2024
Q1 | $5.03K | Hold |
53
| – | – | ﹤0.01% | 633 |
|
|
2023
Q4 | $4.73K | Hold |
53
| – | – | ﹤0.01% | 637 |
|
|
2023
Q3 | $3.87K | Hold |
53
| – | – | ﹤0.01% | 640 |
|
|
2023
Q2 | $4.41K | Buy |
+53
| New | +$4.41K | ﹤0.01% | 627 |
|